Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/1734
Title: Palifermin, administered for three doses only, reduces mucositis in patients undergoing HSCT and receiving chemoradiotherapy conditioning
Authors: Coutsouvelis, John
Dooley, Michael
Kirkpatrick, Carl M
Avery, Sharon 
Hopkins, Ria
Spencer, Andrew
Issue Date: 2022
Publisher: Nature Publishing Group
Source: Coutsouvelis J, Dooley M, Kirkpatrick CM, Avery S, Hopkins R, Spencer A. Palifermin, administered for three doses only, reduces mucositis in patients undergoing HSCT and receiving chemoradiotherapy conditioning. Bone Marrow Transplant. 2022 May 19. doi: 10.1038/s41409-022-01714-6. Epub ahead of print. PMID: 35589999.
Journal: Bone marrow transplantation
Description: Cairns & Hinterland Hospital and Health Service (CHHHS) affiliated author: Sharon Avery
DOI: 10.1038/s41409-022-01714-6
Type: Article
Appears in Sites:Cairns & Hinterland HHS Publications

Show full item record

Page view(s)

16
checked on Dec 10, 2022

Google ScholarTM

Check

Altmetric


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.